{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:38:19Z","timestamp":1791092299644,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.nbd.2010.06.017","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T20:36:30Z","timestamp":1278880590000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"title":["Progressive motor weakness in transgenic mice expressing human TDP-43"],"prefix":"10.1016","volume":"40","author":[{"given":"Nancy R.","family":"Stallings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Puttaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2010.06.017_bb0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2010.06.017_bb0010","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2010.06.017_bb0015","series-title":"Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol aging","author":"Gijselinck","year":"2007"},{"key":"10.1016\/j.nbd.2010.06.017_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","article-title":"TDP-43 A315T mutation in familial motor neuron disease","volume":"63","author":"Gitcho","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2010.06.017_bb0025","doi-asserted-by":"crossref","first-page":"e2450","DOI":"10.1371\/journal.pone.0002450","article-title":"TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis","volume":"3","author":"Guerreiro","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2010.06.017_bb0030","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M809462200","article-title":"Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies","volume":"284","author":"Igaz","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2010.06.017_bb0035","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2010.06.017_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2010.06.017_bb0045","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","article-title":"Rethinking ALS: the FUS about TDP-43","volume":"136","author":"Lagier-Tourenne","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2010.06.017_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2010.06.017_bb0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nbd.2010.06.017_bb0060","doi-asserted-by":"crossref","first-page":"e1000193","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2010.06.017_bb0065","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1074\/jbc.M109.061846","article-title":"TDP-43 is a developmentally-regulated protein essential for early embryonic development","volume":"285","author":"Sephton","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2010.06.017_bb0070","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1073\/pnas.0610923104","article-title":"Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology","volume":"104","author":"Son","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.06.017_bb0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2010.06.017_bb0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mt.2009.3","article-title":"Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression","volume":"17","author":"Tatom","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2010.06.017_bb0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molmed.2008.09.001","article-title":"TDP-43: an emerging new player in neurodegenerative diseases","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2010.06.017_bb0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nbd.2005.06.005","article-title":"Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA","volume":"20","author":"Wang","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.06.017_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng1332","article-title":"Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein","volume":"36","author":"Watts","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2010.06.017_bb0100","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.06.017_bb0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nmd.2009.01.009","article-title":"Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia","volume":"19","author":"Weihl","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2010.06.017_bb0110","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1073\/pnas.0912417107","article-title":"TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration","volume":"107","author":"Wils","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.06.017_bb0115","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","article-title":"Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation","volume":"283","author":"Winton","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2010.06.017_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2008.01.060","article-title":"Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43","volume":"434","author":"Zhang","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2010.06.017_bb0125","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.06.017_bb0130","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1523\/JNEUROSCI.3421-07.2007","article-title":"Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:05:52Z","timestamp":1760850352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996110002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0969996110002135"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2010.06.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive motor weakness in transgenic mice expressing human TDP-43","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2010.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}